Total Funding
1
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-34 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1600151
Dextera designs and manufactures automated anastomosis products designed to replace hand-sewn anastomoses during grafting surgeries.
Bernard A. Hausen: President, CEO, CMO & Director
Kevin T. Larkin: Board ChairmanPast Role: Ventritex, Vice President, Marketing and Sales
About the Company
Dextera Surgical, formerly known as Cardica designs and manufactures proprietary products which automate the connections, or anastomoses, of blood vessels during coronary artery bypass graft (CABG) and other grafting surgeries. Cardica's automated anastomosis products are designed to replace hand-sewn anastomoses, which are time consuming and
difficult to perform.
